Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

0.00

EX-DatePurpose
30 06 2021 Quarterly Results & Audited Results
14 08 2021 Quarterly Results
27 08 2021 Increase in Authorised Capital & A.G.M. Inter alia to transact the following items: 1. To Fix the Date & Time of 32nd Annual General Meeting (AGM) of the Company. 2. To Fix the Dates of Book Closure 3. To Approve the Notice, Boards Report and other reports 4. To Consider the increase of authorised Capital of the company 5. To discuss any other items with the permission of Chairman.
21 10 2021 Quarterly Results
12 01 2022 Quarterly Results & Preferential Issue of shares & Issue Of Warrants
04 02 2022 Increase in Authorised Capital & Bonus issue
20 05 2022 Audited Results
12 07 2022 Quarterly Results
09 11 2022 Quarterly Results
27 01 2023 Preferential Issue of shares & Issue Of Warrants Inter-alia, to consider: 1. Proposal for issuance of equity shares/warrants by way of a preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal of preferential allotment, as required
08 02 2023 Quarterly Results
15 05 2023 Audited Results
14 07 2023 Quarterly Results
13 11 2023 Quarterly Results
19 01 2024 Quarterly Results
24 01 2024 Quarterly Results
06 11 2024 Quarterly Results
21 11 2024 Employees Stock Option Plan
27 01 2025 Quarterly Results & Preferential Issue of shares
28 05 2025 Preferential Issue of shares & Inter alia, t the Board of Directors shall also consider the following additional agenda item in the Board meeting scheduled to be held on Wednesday, May 28, 2025:- 1. Proposal for raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, preferential allotment, private placement, or any other method in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, and other applicable law, to such investors, as may be permitted to invest in such issuance of securities, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal of raising of funds, as required.
14 08 2025 Quarterly Results
22 08 2025 inter-alia to transact the following business. 1. Restructuring the SaaS business into a 100% subsidiary via slump sale to create a focused SaaS entity, thus unlocking long-term shareholder value 2. Divesting a portion of the SaaS business via private investment, strategic partnerships, or IPO, and utilising proceeds to reduce debt at the consolidated level as well as invest in oncology healthcare vertical to expand the Virinchi hospital chain.
15 10 2025 Preferential Issue of shares & Inter alia, to consider the following agenda item: 1. Proposal for raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, preferential allotment, private placement, or any other method in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, and other applicable law, to such investors, as may be permitted to invest in such issuance of securities, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal for raising of funds, as required.
13 11 2025 Quarterly Results
04 02 2026 Quarterly Results

News

28-JAN-2025

Virinchi reports 33% fall in Q3 consolidated net profit

Total income of the company increased by 13.11% at Rs 82.50 crore for Q3FY25

10:55 AM
27-OCT-2023

Virinchi purchases property in Hyderabad

The company has executed a Sale Deed on October 26, 2023, effecting the purchase of a Plot ad-measuring 1290 Square yards along with an old building

09:28 AM
31-JUL-2023

Virinchi enters into agreement with one of leading Micro Lending companies in USA

The initial Term of the agreement is for 5 Years from July 28, 2023

09:39 AM
31-DEC-2022

Virinchi’s arm receives Certificate of Registration for performing live donor liver transplantation

The certificate of Registration is valid for a period of 5 Years

04:54 PM
Enrich money logo